Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Rigshospitalet

Status

Completed

Conditions

Liver Transplantation

Treatments

Procedure: Pre-treatment

Drug: Sirolimus based immunosuppression

Study type

Observational

Funder types

Other

Identifiers

NCT02995096

There is no unique protocol ID

Details and patient eligibility

About

Recurrence after liver transplantation for hepatocellular carcinoma (HCC) represents an important cause of mortality for this surgical population. In addition to tumor characteristics, It has been suggested that pre-treatment and sirolimus-based immunosuppression may affect recurrence and survival. With data from the European Liver Transplant Registry (ELTR) database, the aim of this study is to investigate the impact of tumor characteristics, pre-transplant treatment and immunosuppression regimens on survival after liver transplantation for HCC.

Enrollment

23,124 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria